ArticleBlood advances2020

A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia.

Priyanka Nair-Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.